Phototherapy for the treatment of cutaneous graft versus host disease

KB Garbutcheon‐Singh… - Australasian Journal of …, 2015 - Wiley Online Library
Graft versus host disease (GvHD) occurs in half the patients who receive allogenic
haematopoietic stem cell transplantation and is a major contributor for the morbidity and …

[引用][C] Phototherapy for the treatment of cutaneous graft versus host disease

KB Garbutcheon-Singh… - Australasian Journal of …, 2014 - cir.nii.ac.jp
Phototherapy for the treatment of cutaneous graft versus host disease | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本をさがす 日本の博士 …

Phototherapy for the treatment of cutaneous graft versus host disease

KB Garbutcheon‐Singh… - Australasian Journal of …, 2015 - infona.pl
Graft versus host disease (GvHD) occurs in half the patients who receive allogenic
haematopoietic stem cell transplantation and is a major contributor for the morbidity and …

Phototherapy for the treatment of cutaneous graft versus host disease.

KB Garbutcheon‐Singh… - Australasian Journal of …, 2015 - search.ebscohost.com
Graft versus host disease (GvHD) occurs in half the patients who receive allogenic
haematopoietic stem cell transplantation and is a major contributor for the morbidity and …

Phototherapy for the treatment of cutaneous graft versus host disease.

KB Garbutcheon-Singh… - The Australasian Journal …, 2014 - europepmc.org
Graft versus host disease (GvHD) occurs in half the patients who receive allogenic
haematopoietic stem cell transplantation and is a major contributor for the morbidity and …

Phototherapy for the treatment of cutaneous graft versus host disease

KB Garbutcheon-Singh… - The Australasian …, 2015 - pubmed.ncbi.nlm.nih.gov
Graft versus host disease (GvHD) occurs in half the patients who receive allogenic
haematopoietic stem cell transplantation and is a major contributor for the morbidity and …